Published in
Oxford University Press (OUP), Journal of the National Cancer Institute
DOI: 10.1093/jnci/djy211
Links
Tools
Use of Late-Life Expectancy for Assessing the Long-Term Benefit of Immune Checkpoint Inhibitors
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 